Location: United States, Massachusetts, Boston
Total raised: $50M
Investors 1
| Date | Name | Website |
| - | Apple Tree... | appletreep... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.11.2020 | Series A | $50M | Apple Tree... |
Mentions in press and media 12
| Date | Title | Description |
| 22.09.2025 | Nereid Therapeutics Scientific Co-Founder Clifford Brangwynne Named a 2025 Keio Medical Science Prize Laureate | September 22, 2025/ − Clifford Brangwynne, Ph.D., co-founder of Nereid Therapeutics and professor of chemical and biological engineering at Princeton University, has been selected as a 2025 recipient of the Keio Medical Science Prize in rec... |
| 13.11.2023 | Nereid Therapeutics Appoints Michael Kauffman as CEO | Seasoned industry executive with decades of success in drug discovery, development, regulatory approvals and commercialization will lead Nereid’s work to advance multiple programs towards the clinic |
| 13.11.2023 | Nereid Therapeutics Appoints Michael Kauffman as CEO | Seasoned industry executive with decades of success in drug discovery, development, regulatory approvals and commercialization will lead Nereid’s work to advance multiple programs towards the clinic BOSTON, November 13, 2023 /PRNewswire/ -... |
| 01.11.2021 | Nereid Therapeutics Announces Scientific Advisory Board Membership | BOSTON, Mass., November 1, 2021 /PR Newswire/ – Nereid Therapeutics, a company discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates, announced today the members of its Scientific Ad... |
| 01.11.2021 | Nereid Therapeutics Announces Scientific Advisory Board Membership | BOSTON, Nov. 1, 2021 /PRNewswire/ -- Nereid Therapeutics, a company discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates, announced today the members of its Scientific Advisory Boar... |
| 01.11.2021 | Nereid Therapeutics Announces Scientific Advisory Board Membership | BOSTON, Mass., November 1, 2021 /PR Newswire/ – Nereid Therapeutics, a company discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates, announced today the members of its Scientific Ad... |
| 25.10.2021 | Nereid Therapeutics : Announces Appointments of Laura Forese and Rupert Vessey to Its Board of Directors | BOSTON, Oct. 25, 2021 /PRNewswire/ -- Nereid Therapeutics, a company discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates, announces the appointment of Laura L. Forese, M.D., MPH, a... |
| 16.11.2020 | Nereid Therapeutics Launches: ATP $50M Series A NewCo Co-Founded with Brangwynne, Pioneer of Biomolecular Condensates Field | BOSTON, November 16, 2020/PR NEWSWIRE/ -- Apple Tree Partners (ATP), a leading life sciences venture firm, today announced the launch of Nereid Therapeutics, a company dedicated to discovering new disease treatments by applying pioneering r... |
| 16.11.2020 | Nereid Therapeutics Launches: ATP $50M Series A NewCo Co-Founded with Brangwynne | Apple Tree Partners (ATP), a leading life sciences venture firm, today announced the launch of Nereid Therapeutics, a company dedicated to discovering new disease treatments by applying pioneering research and technologies in biomolecular c... |
| 16.11.2020 | Nereid Therapeutics Raises $50M in Series A Funding | Nereid Therapeutics, a Boston, MA-based company dedicated to discovering new disease treatments by applying research and technologies in biomolecular condensates, raised $50m in Series A funding. Apple Tree Partners (ATP), a life sciences v... |
Show more